Cognizant plans to employ its Neuro AI generative AI platform to assist Gilead in enhancing IT and business processes, with the intent to create value and transform the user experience of IT services.

FOSTER CITY, Calif., February 11, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024. Cognizant (NASDAQ: CTSH ...

Gilead gave the money to doctors who spoke at HIV Speaker Program events in the form of honoraria payments, meals and travel expenses, according to the U.S. Attorney's Office in Manhattan, which ...

April 30 (Reuters) - Cognizant Technology Solutions (CTSH.O), opens new tab raised its annual revenue forecast and beat first-quarter results on Wednesday, driven by increased demand for AI ...